Kalorama Information also offers the report Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends for market insights into selected products used in biomarker and drug discovery research.
Tracked through seven editions of Kalorama Information’s Outsourcing in Drug Discovery, pharmaceutical research and development (R&D) is now pinned between building market pressures and an explosion in the number of techniques and technological platforms necessary to advance drug candidates. For the first time ever, the global pharmaceutical industry in 2010 cut its R&D budget; subsequent R&D spending growth has been tepid relative to the previous decade with additional industry cuts in 2014 and 2015. With a mantra of “fail early, fail cheaply” for handling high drug candidate attrition rates, pharmaceutical companies are outsourcing increasingly specialized work in drug development, especially as their in-house capabilities have been downsized. In the seventh edition of Outsourcing in Drug Discovery, Kalorama Information analyzes key areas of market growth for contract research organizations (CROs) in terms of services in the drug development process.